(MSLC) Morgan Stanley Pathway - Overview
Etf: Large Cap, Equity, Us Stocks, Market Cap
Dividends
| Dividend Yield | 2.14% |
| Yield on Cost 5y | 2.40% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.4% |
| Relative Tail Risk | 3.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.49 |
| Alpha | -2.45 |
| Character TTM | |
|---|---|
| Beta | 0.926 |
| Beta Downside | 0.932 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.86% |
| CAGR/Max DD | 0.62 |
Description: MSLC Morgan Stanley Pathway January 20, 2026
The Morgan Stanley Pathway Large-Cap Equity ETF (MSLC) is designed to allocate at least 80% of its net assets-plus any investment-purpose borrowings-to equities of large-cap companies, defined by the manager as those whose market capitalizations fall within the Russell 1000® Index range. The fund is classified as a “Large Blend” ETF, meaning it holds a mix of growth and value stocks across the U.S. large-cap universe.
Key metrics (as of the most recent public filings, assumed Q4 2024) show an expense ratio of 0.12%, a weighted average market cap of roughly $150 billion, and a sector tilt of ~30% toward information technology, reflecting the sector’s outsized weight in the Russell 1000. Recent macro-economic drivers-such as the Federal Reserve’s stance on interest rates and corporate earnings growth in the tech and consumer discretionary sectors-are likely to influence the ETF’s performance more than any single stock selection.
If you want a deeper, data-driven view of how MSLC’s factor exposures compare to peers, a quick look at ValueRay’s analytics dashboard can help you spot any hidden risks or opportunities.
What is the price of MSLC shares?
Over the past week, the price has changed by -0.54%, over one month by -0.99%, over three months by +2.93% and over the past year by +12.05%.
Is MSLC a buy, sell or hold?
What are the forecasts/targets for the MSLC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 58.2 | 6.2% |
MSLC Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.58b USD (3.58b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.58b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.58b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.33% (E(3.58b)/V(3.58b) * Re(9.33%) + (debt-free company))
Discount Rate = 9.33% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)